|
MIDDLEFIELD HEALTHCARE DIVIDEND ETF
Summary of Investment Portfolio as at September 30, 2023 |
|
|
|
Top Twenty-Five Holdings | |
|
|
|
Description |
% of Net Asset Value |
| |
|
1. |
Eli Lilly & Company |
6.3% |
|
|
2. |
UnitedHealth Group Inc. |
5.0% |
|
|
3. |
Merck & Co., Ltd. |
4.8% |
|
|
4. |
AstraZeneca PLC |
4.8% |
|
|
5. |
AbbVie Inc. |
4.7% |
|
|
6. |
Thermo Fisher Scientific Inc. |
4.6% |
|
|
7. |
Chartwell Retirement Residences |
4.3% |
|
|
8. |
Stryker Corp. |
3.9% |
|
|
9. |
Medtronic PLC |
3.7% |
|
|
10. |
Danaher Corp. |
3.6% |
|
|
11. |
Johnson & Johnson |
3.6% |
|
|
12. |
Becton Dickinson and Co. |
3.5% |
|
|
13. |
Boston Scientific Corp. |
3.3% |
|
|
14. |
Pfizer Inc. |
3.1% |
|
|
15. |
Zoetis Inc. |
3.1% |
|
|
16. |
Sanofi S.A. |
3.1% |
|
|
17. |
Abbott Laboratories |
3.1% |
|
|
18. |
Gilead Sciences Inc. |
2.9% |
|
|
19. |
Novo Nordisk A/S |
2.8% |
|
|
20. |
McKesson Corp. |
2.7% |
|
|
21. |
Edwards Lifesciences Corporation |
2.3% |
|
|
22. |
Humana Inc. |
2.2% |
|
|
23. |
Intuitive Surgical Inc. |
2.1% |
|
|
24. |
Dexcom, Inc. |
2.1% |
|
|
25. |
Amgen Inc. |
1.9% |
|
|
| "Top Twenty-Five Holdings" excludes any temporary cash investments |
| |
|
|
|
Asset Class |
% of Net Asset Value |
| |
| |
Healthcare |
93.3% |
|
| |
Real Estate |
4.3% |
|
| |
Consumer Staples |
1.6% |
|
| |
Cash and Short-Term Investments |
1.2% |
|
| |
Other Assets (Liabilities) |
-0.4% |
|
| | 100.0% | |
|
|
|
Total Net Asset Value |
$150,422,944 |
|
|
|
|
Total Assets |
$151,605,407 |
|
|
| The Summary of Investment Portfolio may change due to ongoing portfolio transactions.Updates to this Summary of Investment Portfolio are posted to www.middlefield.com. |
|
|